PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do
Visit https://www.peervoice.com/ABV860 to view the entire programme with slides. After completing “"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"”, participants will be able to: Discuss recent clinical data on the management of early-stage EGFR-mutant NSCLC; Explain best practices for mutational testing in patients with early-stage EGFR-mutant NSCLC; Develop strategies to improve communication and collaboration among the multidisciplinary team.